Benchmark analyst Bill Sutherland downgraded Tabula Rasa HealthCare to Hold from Buy after the company announced an agreement to be acquired by Nautic Partners for $10.50 in cash per share and combined with Nautic portfolio company ExactCare Pharmacy.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TRHC: